Phenotypic analysis of antigen-specific T lymphocytes - PubMed (original) (raw)

Phenotypic analysis of antigen-specific T lymphocytes

J D Altman et al. Science. 1996.

Erratum in

• Science 1998 Jun 19;280(5371):1821

Abstract

Identification and characterization of antigen-specific T lymphocytes during the course of an immune response is tedious and indirect. To address this problem, the peptide-major histocompatability complex (MHC) ligand for a given population of T cells was multimerized to make soluble peptide-MHC tetramers. Tetramers of human lymphocyte antigen A2 that were complexed with two different human immunodeficiency virus (HIV)-derived peptides or with a peptide derived from influenza A matrix protein bound to peptide-specific cytotoxic T cells in vitro and to T cells from the blood of HIV-infected individuals. In general, tetramer binding correlated well with cytotoxicity assays. This approach should be useful in the analysis of T cells specific for infectious agents, tumors, and autoantigens.

PubMed Disclaimer

Similar articles

• Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
  Hoffmann TK, Donnenberg VS, Friebe-Hoffmann U, Meyer EM, Rinaldo CR, DeLeo AB, Whiteside TL, Donnenberg AD. Hoffmann TK, et al. Cytometry. 2000 Dec 1;41(4):321-8. Cytometry. 2000. PMID: 11084618
• Expansion of CD8+ cytotoxic T cells in vitro and in vivo using MHC class I tetramers.
  Savage P, Millrain M, Dimakou S, Stebbing J, Dyson J. Savage P, et al. Tumour Biol. 2007;28(2):70-6. doi: 10.1159/000099152. Epub 2007 Jan 29. Tumour Biol. 2007. PMID: 17264539
• Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1.
  Tsomides TJ, Aldovini A, Johnson RP, Walker BD, Young RA, Eisen HN. Tsomides TJ, et al. J Exp Med. 1994 Oct 1;180(4):1283-93. doi: 10.1084/jem.180.4.1283. J Exp Med. 1994. PMID: 7523570 Free PMC article.
• [MHC-multimers and their application in studies of antiviral immune response].
  Karpenko LI, Mechetina LV, Reguzova AIu. Karpenko LI, et al. Zh Mikrobiol Epidemiol Immunobiol. 2011 Mar-Apr;(2):112-9. Zh Mikrobiol Epidemiol Immunobiol. 2011. PMID: 21598627 Review. Russian.
• T-cell-mediated cytotoxicity against HIV in seropositive patients: a physiopathological approach.
  Autran B, Joly P, Guillon JM, Denis M, Mayaud C, Debré P. Autran B, et al. Res Immunol. 1989 Jan;140(1):103-7; discussion 120-1. doi: 10.1016/0923-2494(89)90013-8. Res Immunol. 1989. PMID: 2657906 Review. No abstract available.

Cited by

• Detection of rare autoreactive T cell subsets in patients with pemphigus vulgaris.
  Polakova A, Kauter L, Ismagambetova A, Didona D, Solimani F, Ghoreschi K, Hertl M, Möbs C, Hudemann C. Polakova A, et al. Front Immunol. 2022 Sep 20;13:979277. doi: 10.3389/fimmu.2022.979277. eCollection 2022. Front Immunol. 2022. PMID: 36203615 Free PMC article.
• CD8+ TCR Bias and Immunodominance in HIV-1 Infection.
  Kløverpris HN, McGregor R, McLaren JE, Ladell K, Harndahl M, Stryhn A, Carlson JM, Koofhethile C, Gerritsen B, Keşmir C, Chen F, Riddell L, Luzzi G, Leslie A, Walker BD, Ndung'u T, Buus S, Price DA, Goulder PJ. Kløverpris HN, et al. J Immunol. 2015 Jun 1;194(11):5329-45. doi: 10.4049/jimmunol.1400854. Epub 2015 Apr 24. J Immunol. 2015. PMID: 25911754 Free PMC article.
• Technology meets TILs: Deciphering T cell function in the -omics era.
  Hudson WH, Wieland A. Hudson WH, et al. Cancer Cell. 2023 Jan 9;41(1):41-57. doi: 10.1016/j.ccell.2022.09.011. Epub 2022 Oct 6. Cancer Cell. 2023. PMID: 36206755 Free PMC article. Review.
• Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology.
  Blanchfield JL, Shorter SK, Evavold BD. Blanchfield JL, et al. Front Immunol. 2013 Jul 3;4:170. doi: 10.3389/fimmu.2013.00170. eCollection 2013. Front Immunol. 2013. PMID: 23840195 Free PMC article.
• Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals.
  Pachnio A, Begum J, Fox A, Moss P. Pachnio A, et al. PLoS One. 2015 Apr 29;10(4):e0125287. doi: 10.1371/journal.pone.0125287. eCollection 2015. PLoS One. 2015. PMID: 25923913 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Immune Epitope Database and Analysis Resource

• Research Materials

  • NCI CPTC Antibody Characterization Program